Cargando…
Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020
Newborn screening (NBS) is a state or territory-based public health system that screens newborns for congenital diseases that typically do not present with clinical symptoms at birth but can cause significant mortality and morbidity if not detected or treated quickly. NBS continues to be one of the...
Autores principales: | Gaviglio, Amy, McKasson, Sarah, Singh, Sikha, Ojodu, Jelili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123626/ https://www.ncbi.nlm.nih.gov/pubmed/37092517 http://dx.doi.org/10.3390/ijns9020023 |
Ejemplares similares
-
Expanding Newborn Screening for Pompe Disease in the United States: The NewSTEPs New Disorders Implementation Project, a Resource for New Disorder Implementation
por: Hale, Kshea, et al.
Publicado: (2020) -
Infants with Congenital Disorders Identified Through Newborn Screening — United States, 2015–2017
por: Sontag, Marci K., et al.
Publicado: (2020) -
Development of National Newborn Screening Quality Indicators in the United States
por: Yusuf, Careema, et al.
Publicado: (2019) -
Landscape of Spinal Muscular Atrophy Newborn Screening in the United States: 2018–2021
por: Hale, Kshea, et al.
Publicado: (2021) -
Implementing Statewide Newborn Screening for New Disorders: U.S. Program Experiences
por: Kellar-Guenther, Yvonne, et al.
Publicado: (2020)